Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
biotech
6
×
boston blog main
boston top stories
life sciences
national blog main
new york blog main
6
×
new york top stories
national top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
deals
merck
pfizer
president trump
roche
sanofi
startups
abbvie
albert bourla
bristol-myers squibb
cancer immunotherapy
clinical trials
What
today
6
×
drug
annual
biotech
cancer
clinical
future
medicines
oncology
roundup
society
acquisitions
ahead
aiming
albert
ambien
ambys
american
asco
attendees
attention
away
big
biggest
bio
bourla
breast
bringing
camp’s
cancer's
cash
ceo
ceos
chicago
city
combinations
community’s
company
company’s
conference
Language
unknown
unset
Current search:
today
×
biotech
×
" new york blog main "
×
photo
×
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com
6 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More